Evolva Successfully Completes Roquette Collaboration
02 Nov 2015 --- Evolva has announced the successful completion of the collaboration with Roquette Frères (Roquette), which started in January 2012. The project focussed on an ingredient with important applications in food products.
This concludes Evolva’s contribution to the project and Roquette will be responsible for the further steps towards commercial production. Evolva is entitled to a final payment within the next few weeks, based on the value added by Evolva’s production route. The payment amounts to CHF 1.2 million and has no impact on the financial outlook for 2015.
Thierry Marcel, Executive Vice President Research & Development of Roquette said: “We are very pleased with the contribution Evolva made to our never ending drive to get better and go further. Evolva’s dedicated team of scientists came up with an elegant and efficient production route to this important ingredient. We may turn to Evolva again in future.”
Neil Goldsmith, CEO of Evolva added: “I am very proud of the fact that Evolva delivered this successful outcome. We over-delivered, while staying within the agreed time frame and budget. This is an excellent example of us providing our partners with a competitive edge.”
After the completion of the Roquette project, Evolva is now internally pursuing the development of an additional ingredient. This additional ingredient is aimed at a very different application area, but derives from a pathway, related to Roquette’s target product. Whilst early, the development builds upon the high performance strains developed during the collaboration with Roquette.
